Examine how the BioE3 Policy 2024 can transform India into a global biomanufacturing hub. What challenges remain?

Approved by the Union Cabinet on 24 August 2024, the BioE3 Policy — Biotechnology for Economy, Environment and Employment — seeks to shift India from a services-led biotech economy to high-performance biomanufacturing. With the bioeconomy rising from ~$10 billion (2014) to ~$190 billion in 2026 [1], the policy is the institutional scaffolding for the $300 billion target by 2030 [4].

How BioE3 can build a global biomanufacturing hub

• Infrastructure backbone: creation of Biofoundries, Biomanufacturing Hubs and Bio-AI Hubs under the Department of Biotechnology (DBT), with BIRAC as implementing arm, bridges the lab-to-market "valley of death" [2].
• Thematic focus: six priority sectors — bio-based chemicals and enzymes, smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and utilisation, marine and space biotech — target import substitution in high-value molecules [2].
• Green growth: a regenerative bioeconomy model links manufacturing to net-zero goals through biopolymers and carbon capture, aligning with SDG 9 and SDG 13 [2].
• Employment and startups: biotech startups grew from about 50 in 2014 to 8,531 by 2023, showing an absorptive innovation base for skilled job creation [4].
• Demonstrated capability: the indigenous COVID-19 vaccine ecosystem established credibility as a trusted global supplier [1].

Challenges that remain

• Low R&D intensity: gross R&D spending remains well under 1% of GDP, with limited private participation, unlike leading biomanufacturing economies.
• Regulatory complexity: multiple clearances (GEAC, CDSCO, biosafety) slow scale-up despite single-window intent.
• Skill and infrastructure gaps: shortage of fermentation-scale bioprocess engineers; hubs remain concentrated in a few western and southern clusters.
• Feedstock and IP dependence: reliance on imported enzymes, reagents and foreign patents raises costs.

BioE3 is therefore necessary but not sufficient — its promise rests on execution. Sustained R&D financing through the ANRF, faster risk-proportionate regulatory clearance, and federal roll-out via state MoUs can convert policy intent into industrial capacity. Realised well, biomanufacturing can make India's growth simultaneously self-reliant, employment-rich and ecologically sustainable.